
ML Strategies
Viewpoints
Filter by:
Massachusetts FY2021 Conference Report
December 7, 2020 | Blog | By Steven Baddour, Daniel Connelly, Caitlin Beresin, Kaitlyn Sprague, Taylor Shepherd
The fiscal year 2021 (“FY2021”) budget process has been anything but typical. Shortly after Governor Baker’s budget proposal was released in January, the COVID-19 pandemic struck, reorienting the legislative calendar for the remainder of the 2019-2020 legislative session.
Read more
Post-Election 2020 - Health Care Preview
November 23, 2020 | Blog | By Alexander Hecht, Anthony DeMaio, Tara E. Dwyer
With the presidential transition underway, we now look forward to what the Biden administration will seek to accomplish, particularly in the realm of health care policy.
Read more
Senate Passes IoT Cybersecurity Bill by Unanimous Consent
November 18, 2020 | Blog | By Christian Tamotsu Fjeld, Christopher Harvie
MLS Election Update: Impact on Trade
November 10, 2020 | Blog | By R. Neal Martin, Robert Kidwell, Alexander Hecht, Anthony DeMaio
Read about the post-election impact on international trade matters and the incoming administration's influence on the Committee on Foreign Investments in the U.S. (CFIUS).
Read more
Massachusetts Congressional Delegation to the 117th Congress
November 10, 2020 | Blog | By Anthony DeMaio
Read about the Massachusetts congressional delegation to the 117th Congress, their current and potential committee assignments, and possible policy implications.
Read more
MLS Election Update: Clean Tech, Energy & Environment
November 9, 2020 | Blog | By R. Neal Martin
Read about how the administration of President-Elect Joe Biden could shape clean tech, energy, and environmental policy in a divided government.
Read more
Twitter, Facebook, Google Heads Testify on Section 230 and Local Journalism
October 29, 2020 | Blog | By Christian Tamotsu Fjeld, Christopher Harvie
FDA Provides Update on Pre-Cert Program and Launches Digital Health Center of Excellence
October 19, 2020 | Blog
You’d be forgiven in the current climate of coronavirus and election season, to name just a couple hot issues of the day, for missing two recent announcements from the FDA about its digital health program. On September 14, 2020, FDA published “Developing the Software Precertification Program: Summary of Learnings and Ongoing Activities” and the following week, on September 22, launched the Digital Health Center of Excellence.
Read more
Executive Compensation Practices in Pharma – Insight into Congressional Oversight
October 7, 2020 | Blog | By Alexander Hecht, Anthony DeMaio
Massachusetts Legislature Negotiating Extending the 2019-2020 Session Beyond July 31st
July 30, 2020 | Blog | By Steven Baddour, Daniel Connelly, Kaitlyn Sprague, Taylor Shepherd
Beyond COVID: House Committee Advances Several FDA-Related Bills
July 23, 2020 | Blog | By Margaret Jewett
Despite the COVID-19 pandemic, the House Energy & Commerce Committee continues work on several health policy issues, including Orphan Drug Act reform and continuous manufacturing.
Read more
Democrats Lay Groundwork for Infrastructure & Clean Energy Ahead of General Election
July 20, 2020 | Blog | By Thomas Burton, R. Neal Martin
Senate & House Advance PPP Extension: Setting Stage for Next COVID-19 Stimulus Package
July 2, 2020 | Blog | By Alexander Hecht, R. Neal Martin, Anthony DeMaio
Cantwell-Cassidy Exposure Notification Privacy Act – A Bipartisan Bill on Disease Contact Tracing
June 9, 2020 | Blog | By Christian Tamotsu Fjeld, Christopher Harvie
The Implications of Trump's Executive Order and Section 230 of the Communications Decency Act
June 3, 2020 | Blog | By Christian Tamotsu Fjeld, Christopher Harvie
Massachusetts’ Speaker of the House Robert DeLeo Delivers Remote Chamber Address on Vision for the Remainder of Legislative Session
May 21, 2020 | Blog | By Steven Baddour, Daniel Connelly, Caitlin Beresin, Kaitlyn Sprague, Taylor Shepherd
Massachusetts’ Reopening Advisory Board Releases Reopening Report
May 18, 2020 | Blog | By Steven Baddour, Daniel Connelly, Kaitlyn Sprague, Caitlin Beresin, Taylor Shepherd
Today, the Baker-Polito Administration’s Reopening Advisory Board published their report outlining a 4-phase schedule for reopening the Commonwealth since the closure of non-essential businesses on March 23.
Read more
ML Strategies COVID-19 Insights Week In Review — May 15, 2020
May 15, 2020 | Article
This update covers federal and Massachusetts responses to the pandemic, including the House Democrats’ phase 4 economic stimulus proposal, the SBA’s report on PPP implementation plus criticism of how it manages EIDL, and Massachusetts’s reopening plan and its proposed $1B supplemental budget to cover Covid-19 spending.
Read more
ML Strategies COVID-19 Insights Week In Review — May 8, 2020
May 8, 2020 | Article
This update covers federal and Massachusetts responses to the pandemic, including the U.S. Treasury Implementation of CARES Act programs, new proposals for small- and mid-sized businesses, the Paycheck Protection Program (PPP), and new Massachusetts rules related to masks, car dealers, and retailers.
Read more
Next Steps for 21st Century Cures 2.0
May 8, 2020 | Blog
On Monday, April 27, Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) announced the next steps for 21st Century Cures 2.0 (Cures 2.0), legislation that will build on the original 21st Century Cures Act enacted in December 2016 (Cures 1.0). While Cures 1.0 aimed to speed up the process of bringing new treatments to market, Cures 2.0 is generally envisioned to emphasize public health and streamlined care delivery, particularly in light of the COVID-19 pandemic. Elements envisioned to be in Cures 2.0 were outlined in a recently published concept paper that we discuss in this post.
Read more